Piper Sandler Warns Strait of Hormuz Closure Could Push Oil to New Highs This Summer Shah Metacorp Surges 6 on 498 Crore Rights Issue for Expansion and Renewable Energy Entry T Rowe Prices Tony Wang Shifts AI Focus to Space and Bottlenecks After Nvidia Success HarleyDavidson Analyst Report Highlights Market Position and Strategy Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project The Pothole Puzzle Britains 186bn Road Repair Backlog and Its Economic Impact NWBI Q1 2026 Earnings Earnings Surpass Estimates as Stock Declines Amid Broader Market Pressure Village Farms International VFF Q1 2026 Earnings EPS Misses Estimates Slightly Amid Undisclosed Revenue INFU Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Slides Lower CRGY Q1 2026 Earnings Earnings Surge Past Estimates as Operational Efficiency Drives Strong Results Modiv Industrial Inc Class C MDV Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Legato Merger Corp III LEGT Q1 2026 Earnings Positive EPS Reported Amid PreMerger Quiet Period Ollies Bargain Outlet OLLI Gains 5 as Discount Retailer Shows Resilience MVSTW Warrants Continue to Trade at Penny Levels Amid Minimal Price Action Caledonia Mining CMCL Faces Selling Pressure Key Support Levels in Focus Rezolve AI RZLV Dips 192 as Stock Approaches Support Zone California Resources Corporation CRC Advances 131 Approaching Key Resistance Level Hexcel Corporation Q1 2026 Earnings EPS Surges Past Estimates Signaling Robust Operational Efficiency Navios Maritime Partners NMM Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds EXFY Q1 2026 Earnings EPS Beats Estimates by 68 Stock Rises Wintrust Financial WTFCN Q1 2026 Earnings Solid EPS Beat Driven by Strong Net Interest Income AVX Q1 2026 Earnings Narrow Loss Reported Amidst Limited Disclosure CZNC Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Edges Higher UK Exports to US Plunge 25 Following Trump Tariffs Resulting in Trade Deficit LSBK Q3 2025 Earnings EPS of 032 Stands Alone Amid Sparse Disclosure Foghorn Therapeutics FHTX Rises 144 as Biotech Stock Tests Key Resistance at 443